Midkine can be evaluated as a new ovarian reserve marker at polycystic ovary syndrome cases except for unexplained infertility cases
Keyword(s):
2018 ◽
Vol 35
(3)
◽
pp. 228-232
◽
2017 ◽
Vol 2
(1)
◽
pp. 004-008
◽
2018 ◽
Vol 109
(3)
◽
pp. 516-525.e1
◽
2018 ◽
Vol 25
(6)
◽
pp. 1075-1079
◽
2017 ◽
Vol 217
(2)
◽
pp. 191.e1-191.e19
◽
Keyword(s):
2018 ◽
Vol 34
(9)
◽
pp. 789-792
◽
2019 ◽
Vol 111
(5)
◽
pp. 1011-1019.e1
◽
2013 ◽
Vol 31
(06)
◽
pp. 452-461
◽